Literature DB >> 1447628

Cow milk allergy in infancy and hypoallergenic formulas.

R E Kleinman1.   

Abstract

Substitute feedings have been used to treat infants with cow milk protein allergy for most of this century. For the past 50 years, several infant formulas based on animal proteins, both intact and chemically modified, or on vegetable protein have been labeled "hypoallergenic." Because of the risk of anaphylaxis and other serious adverse reactions, formulas that are claimed to be hypoallergenic should be subjected to rigorous preclinical and clinical testing. At a minimum, such formulas should not provoke any allergic signs or symptoms in 90% of infants with documented cow milk protein allergy when tested in double-blind, placebo-controlled trials. A standardized definition of "hypoallergenic" will allow clinicians and parents to understand the true risks to a cow milk-allergic infant fed such hypoallergenic formulas.

Entities:  

Mesh:

Year:  1992        PMID: 1447628     DOI: 10.1016/s0022-3476(05)81419-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

Review 1.  Dietary products used in infants for treatment and prevention of food allergy. Joint Statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition.

Authors:  A Høst; B Koletzko; S Dreborg; A Muraro; U Wahn; P Aggett; J L Bresson; O Hernell; H Lafeber; K F Michaelsen; J L Micheli; J Rigo; L Weaver; H Heymans; S Strobel; Y Vandenplas
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

2.  Treatment and prevention of milk allergy.

Authors:  S P Galant
Journal:  West J Med       Date:  1993-06

3.  Randomized Trial of a Yogurt-type Amino Acid-based Formula in Infants and Children With Severe Cow's Milk Allergy.

Authors:  François Payot; Alain Lachaux; Florent Lalanne; Nicolas Kalach
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-01       Impact factor: 2.839

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.